IJCS | Volume 31, Nº6, November / December 2018

593 31. HuDC, Wong EF, WongNL. The differential response in atrial natriuretic peptide release during exercise in patients with and without ischemic heart disease. Am J Med Sci. 1988;296(2):111-3. 32. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Tanaka S, et al. Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies. Int J Legal Med. 2007;121(1):28-35. 33. Tanaka H, Shindo M, Gutkowska J, Kinoshita A, Urata H, Ikeda M, et al. Effect of acute exercise on plasma immunoreactive-atrial natriuretic factor. Life Sci. 1986;39(18):1685-93. 34. Vogelsang TW, Yoshiga CC, Højgaard M, Kjaer A, Warberg J, Secher NH, et al. The plasma atrial natriuretic peptide response to arm and leg exercise in humans: effect of posture. Exp Physiol. 2006;91(4):765-71. 35. Haller BG, Züst H, Shaw S, Gnädinger MP, Uehlinger DE, Weidmann P. Effects of posture and ageing on circulating atrial natriuretic peptide levels in man. J Hypertens. 1987;5(5):551-6. 36. Engelmann MD, Niemann L, Kanstrup IL, Skagen K, Godtfredsen J. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. Int J Cardiol. 2005;105(1):31-9. 37. Barletta G, Stefani L, Del Bene R, Fronzaroli C, Vecchiarino S, Lazzeri C, et al. Effects of exercise on natriuretic peptides and cardiac function in man. Int J Cardiol. 1998;65(3):217-25. 38. Iemitsu M, Miyauchi T, Maeda S, Tanabe T, Takanashi M, Irukayama- Tomobe Y, et al. Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training. Am J Physiol Heart Circ Physiol. 2002;283(5):H1750-60. 39. Thaman R, Esteban MT, Barnes S, Gimeno JR, Mist B, Murphy R, et al. Usefulness of N-terminal pro-B-type natriuretic peptidelevels to predict exercise capacity in hypertrophic cardiomyopathy. Am J Cardiol. 2006;98(4):515-9. 40. Novaes RD, Penitente AR, Gonçalves RV, Talvani A, Peluzio MC, Neves CA, et al. Trypanosomacruzi infection induces morphological reorganization of themyocardiumparenchyma and stroma, andmodifies the mechanical properties of atrial and ventricular cardiomyocytes in rats. Cardiovasc Pathol. 2013;22(4):270-9. 41. Riegger AJ, Kromer EP, Kochsiek K. Atrial natriuretic peptide in patients with severe heart failure. Klin Wochenschr. 1986;64 Suppl 6:89-92. 42. Awazu M, Imada T, Kon V, Inagami T, Ichikawa I. Role of endogenous atrial natriuretic peptide in congestive heart failure. Am J Physiol. 1989;257(3 Pt 2):R641-6. 43. Cantin M, Gutkowska J, Thibault G, Milne RW, Ledoux S, MinLi S, et al. Immunocytochemical localization of atrial natriuretic factor in the heart and salivary glands. Histochemistry.1984;80(2):113-27. 44. Riegger GA, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, et al. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation. 1988;77(2):398-406. Ferraboli et al. Effect of mild aerobic exercise in Chagas’disease Int J Cardiovasc Sci. 2018;31(6)585-593 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License